Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
Financial Results:
- Jubilant Ingrevia Ltd reported Revenues for Q1FY24 of ₹1,075.00 Crores down from ₹1,166.00 Crore year on year, a fall of 7.8%.
- Total Expenses for Q1FY24 of ₹1,001.00 Crores down from ₹1,060.00 Crores year on year, a fall of 5.57%.
- Consolidated Net Profit of ₹58.00 Crores down 26.58% from ₹79.00 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹3.62, down 27.31% from ₹4.98 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.